Retraction note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex (Leukemia, (2012), 26, 4, (778-787), 10.1038/leu.2011.287)

M. Konopleva, M. Milella, P. Ruvolo, J. C. Watts, M. R. Ricciardi, B. Korchin, McQueen Teresa, William Bornmann, T. Tsao, P. Bergamo, D. H. Mak, W. Chen, J. McCubrey, A. Tafuri, M. Andreeff

Research output: Contribution to journalComment/debatepeer-review

Abstract

Retraction Note to: Leukemiahttps://doi.org/10.1038/leu.2011.287 The Editors-in-Chief have retracted this article after concerns were raised about the data. In Figure 6a, several images of mice appear to have been duplicated, while the bioluminescence signals of these images differ. As a result of these issues, the Editors-in-Chief no longer have confidence in the reliability of these data or the conclusions presented in the article. D H Mak and J McCubrey stated that they neither agree nor disagree with this retraction. M Konopleva and M Andreeff disagree with this retraction. The remaining authors did not respond to correspondence from the Publisher about this retraction.

Original languageEnglish (US)
Pages (from-to)2072
Number of pages1
JournalLeukemia
Volume38
Issue number9
DOIs
StatePublished - Sep 2024
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Retraction note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex (Leukemia, (2012), 26, 4, (778-787), 10.1038/leu.2011.287)'. Together they form a unique fingerprint.

Cite this